Rivaroxaban News and Research

RSS
Research offers a cost-effectiveness analysis of anticoagulant drugs for cancer-associated thrombosis

Research offers a cost-effectiveness analysis of anticoagulant drugs for cancer-associated thrombosis

Cost-effectiveness analysis of four interventions for treatment of cancer-associated thrombosis

Cost-effectiveness analysis of four interventions for treatment of cancer-associated thrombosis

Direct oral anticoagulants more effective and cost-effective for treating cancer-associated thrombosis

Direct oral anticoagulants more effective and cost-effective for treating cancer-associated thrombosis

Does nirmatrelvir and ritonavir reduce the risk of hospitalization or death among outpatients with early COVID-19?

Does nirmatrelvir and ritonavir reduce the risk of hospitalization or death among outpatients with early COVID-19?

No benefit of low dose apixaban following acute COVID-19

No benefit of low dose apixaban following acute COVID-19

Additional six weeks of anti-clotting treatment reduces further clot risk after distal DVT

Additional six weeks of anti-clotting treatment reduces further clot risk after distal DVT

Study explores the effect of COVID-19 on platelet function

Study explores the effect of COVID-19 on platelet function

SARS-CoV-2 infection may be a trigger of myelin oligodendrocyte glycoprotein-associated disorder

SARS-CoV-2 infection may be a trigger of myelin oligodendrocyte glycoprotein-associated disorder

Low-dose apixaban treatment reduces recurrence of venous thromboembolism compared to anticoagulant discontinuation after negative D-dimer

Low-dose apixaban treatment reduces recurrence of venous thromboembolism compared to anticoagulant discontinuation after negative D-dimer

Many treatments for intracerebral hemorrhage are not as effective as previously thought, guideline suggests

Many treatments for intracerebral hemorrhage are not as effective as previously thought, guideline suggests

Reduced kidney function caused by antithrombotic therapy can influence bleeding events

Reduced kidney function caused by antithrombotic therapy can influence bleeding events

Meta-analysis finds intensified anticoagulation had no effect on short term mortality among hospitalized COVID-19 patients

Meta-analysis finds intensified anticoagulation had no effect on short term mortality among hospitalized COVID-19 patients

Impact of atrial fibrillation in COVID-19 vaccine-induced pericarditis patients

Impact of atrial fibrillation in COVID-19 vaccine-induced pericarditis patients

Trial tests effectiveness of two prospective stroke therapies over standard of care

Trial tests effectiveness of two prospective stroke therapies over standard of care

Study elucidates the use of anticoagulants to treat bleeding in patients with gastrointestinal cancers

Study elucidates the use of anticoagulants to treat bleeding in patients with gastrointestinal cancers

Rivaroxaban reduces the occurrence of severe ischemic events in patients with peripheral artery disease

Rivaroxaban reduces the occurrence of severe ischemic events in patients with peripheral artery disease

Study shows adverse outcomes associated with use of more blood thinners

Study shows adverse outcomes associated with use of more blood thinners

Dual-pathway approach can lead to better outcomes in patients with heart stents

Dual-pathway approach can lead to better outcomes in patients with heart stents

Study provides indications and techniques of lower extremity revascularization

Study provides indications and techniques of lower extremity revascularization

Clopidogrel added to aspirin and rvaroxaban shows no additional benefit for peripheral artery disease

Clopidogrel added to aspirin and rvaroxaban shows no additional benefit for peripheral artery disease